GFAP and epilepsy: Mitotic labeling with Ki‐67 and double‐labeling with GFAP and/or with fluorescent astrocytes would possibly enable the determination of the degree of de novo astrocyte proliferation at various time points during epileptogenesis in rodent models of epilepsy.